(Q62698433)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

D N Sang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

8 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1570-1573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18607560%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-008-1078-9

10 January 2020

exact match

0 references

cites work

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

1 reference

12 December 2020

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab

1 reference

12 December 2020

Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7

1 reference

12 December 2020

Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways.

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Pathophysiological consequences of VEGF-induced vascular permeability

1 reference

12 December 2020

Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group

1 reference

12 December 2020

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

12 December 2020

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

1 reference

12 December 2020

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.

1 reference

12 December 2020

Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients

1 reference

12 December 2020

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

1 reference

12 December 2020

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

1 reference

12 December 2020

Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.

1 reference

12 December 2020

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

1 reference

12 December 2020

Vascular endothelial cell growth factor-a: not just for endothelial cells anymore.

1 reference

12 December 2020

Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.

1 reference

12 December 2020

Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

1 reference

12 December 2020

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

1 reference

12 December 2020

The fast oscillation of the EOG in diabetes with and without mild retinopathy

1 reference

12 December 2020

Inhibitors of ocular neovascularization: promises and potential problems.

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

1 reference

12 December 2020

VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema

1 reference

12 December 2020

Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus

1 reference

12 December 2020

VEGF expression and receptor activation in the choroid during development and in the adult.

1 reference

12 December 2020

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

1 reference

12 December 2020

Vascular endothelial growth factor localization in the adult.

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

1 reference

12 December 2020

Development and pathology of the hyaloid, choroidal and retinal vasculature.

1 reference

12 December 2020